cardioscale.comAbout company
CardioScale is a medical device company, focusing on early detection of cardiovascular hemodynamic deterioration. CardioScale is revolutionizing patient care by predicting deterioration in patients, even when their vital signs are within a normal range, which enables medical staff to make informed decisions regarding intervention, and ultimately, save lives. Shock, Sepsis, Trauma, ICU, pre\post-operation and chronic condition such as congestive heart failure, can all be monitored by the patented CVRI. CVRI is a unique and advanced indicator that assesses a patient’s hemodynamic state and trend to accurately projects its developing hemodynamic condition, without taking any invasive measures. CardioScale was founded by Ben-Zion Bobrovsky in 2012.
